X0306 4 2017-06-15 false 0001271214 Intersect ENT, Inc. XENT 0001530893 Earnhardt Lisa D C/O INTERSECT ENT, INC. 1555 ADAMS DRIVE MENLO PARK CA 94025 true true false false President and CEO Common Stock 2017-06-15 4 M false 2625.00 1.20 A 583493.00 D Common Stock 2017-06-15 4 M false 7375.00 1.20 A 590868.00 D Common Stock 2017-06-15 4 S false 20000.00 26.0989 D 570868.00 D Common Stock 26182.00 I See footnote Stock Option (right to buy) 1.20 2017-06-15 4 M false 7375.00 0.00 D 2023-04-22 Common Stock 7375.00 0.00 D Stock Option (right to buy) 1.20 2017-06-15 4 M false 2625.00 0.00 D 2023-04-22 Common Stock 2625.00 58016.00 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2016. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.75 to $26.40, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote on this Form 4. Shares in the name of Lisa Damkroger Earnhardt C/F Jack L. Earnhardt UTMA/CA Until Age 25 for the benefit of Reporting Person's son. Reporting Person disclaims beneficial ownership of these shares. The shares subject to the option vest commencing April 23, 2013 in monthly equal installments over four years. The shares subject to the option vest commencing November 30, 2013 in monthly equal installments over four years. /s/ David A. Lehman, Attorney-in-Fact for Lisa D. Earnhardt 2017-06-19